Thomas Dietz - Aug 23, 2023 Form 4 Insider Report for LEAP THERAPEUTICS, INC. (LPTX)

Role
Director
Signature
/s/ Douglas E. Onsi as attorney-in-fact for Thomas Dietz
Stock symbol
LPTX
Transactions as of
Aug 23, 2023
Transactions value $
$0
Form type
4
Date filed
8/25/2023, 04:31 PM
Previous filing
Apr 4, 2023
Next filing
Sep 21, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LPTX Stock Option (Right to Buy) Award $0 +17.5K $0.00 17.5K Aug 23, 2023 Common Stock 17.5K $2.21 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Option was granted pursuant to Leap's 2022 Equity Incentive Plan, as amended. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 4 quarterly installments on each of November 23, 2023, February 23, 2024, May 23, 2024 and August 23, 2024 for so long as the reporting person continues to be a director, consultant or service provider of the Company.